News|Articles|August 23, 2023
How Aizon Helps Leading Biotech Company Use AI to Improve Yield
Author(s)Aizon
This case study shares why a leading biotech company reached out to Aizon to identify how artificial intelligence (AI) could be used to further optimize yield. The team was able to analyze five years of historical batch data to discover a direct correlation between hold up volume and time between process operations as well as generating millions of additional recovered revenue.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
How ten23 health is Advancing Patient-Centric Drug Delivery
2
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II
3
FDA, Duke University Planning Epinephrine Access Workshop for December
4
Drug Solutions Podcast: Innovations in Orphan Drugs for Rare Diseases
5
